157 related articles for article (PubMed ID: 7544547)
1. Pharmacokinetic interaction between risperidone and clozapine.
Tyson SC; Devane CL; Risch SC
Am J Psychiatry; 1995 Sep; 152(9):1401-2. PubMed ID: 7544547
[No Abstract] [Full Text] [Related]
2. [New psychopharmacologic alternatives in treatment of schizophrenia].
Bryois C
Schweiz Arch Neurol Psychiatr (1985); 1994; 145(6):19-24. PubMed ID: 7533941
[TBL] [Abstract][Full Text] [Related]
3. Risperidone: integrating research and practice.
Addington D
Br J Hosp Med; 1994 Sep 7-20; 52(5):223-4. PubMed ID: 7529628
[TBL] [Abstract][Full Text] [Related]
4. Remission of drug-induced hepatitis after switching from risperidone to paliperidone.
Paulzen M; Orfanos S; Gründer G
Am J Psychiatry; 2010 Mar; 167(3):351-2. PubMed ID: 20194492
[No Abstract] [Full Text] [Related]
5. New antipsychotic agent, risperidone, introduced.
Am J Hosp Pharm; 1994 May; 51(9):1145. PubMed ID: 7518997
[No Abstract] [Full Text] [Related]
6. Risperidone augmentation of clozapine.
McCarthy RH; Terkelsen KG
Pharmacopsychiatry; 1995 Mar; 28(2):61-3. PubMed ID: 7542786
[TBL] [Abstract][Full Text] [Related]
7. Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugs.
DeVane CL
Am J Health Syst Pharm; 1995 Feb; 52(3 Suppl 1):S15-8. PubMed ID: 7538435
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives raise plasma clozapine concentrations.
Bookholt DE; Bogers JP
J Clin Psychopharmacol; 2014 Jun; 34(3):389-90. PubMed ID: 24717251
[No Abstract] [Full Text] [Related]
9. Risperidone.
Livingston MG
Lancet; 1994 Feb; 343(8895):457-60. PubMed ID: 7508541
[No Abstract] [Full Text] [Related]
10. Increased efficacy with addition of clozapine to aripiprazole: alternative explanations.
DeQuardo JR
J Clin Psychiatry; 2005 Mar; 66(3):396; author reply 396. PubMed ID: 15766312
[No Abstract] [Full Text] [Related]
11. Risperidone augmentation of clozapine: a critical review.
Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Pappa DA; Christodoulou GN
Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):350-5. PubMed ID: 16900439
[TBL] [Abstract][Full Text] [Related]
12. Is risperidone a substitute for clozapine for patients who do not respond to neuroleptics?
Lacey RL; Preskorn SH; Jerkovich GS
Am J Psychiatry; 1995 Sep; 152(9):1401. PubMed ID: 7544546
[No Abstract] [Full Text] [Related]
13. Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients.
Mesotten F; Suy E; Pietquin M; Burton P; Heylen S; Gelders Y
Psychopharmacology (Berl); 1989; 99(4):445-9. PubMed ID: 2480616
[TBL] [Abstract][Full Text] [Related]
14. Risperidone: review of its pharmacology and therapeutic use in schizophrenia.
Gupta S; Black DW; Smith DA
Ann Clin Psychiatry; 1994 Sep; 6(3):173-80. PubMed ID: 7533585
[TBL] [Abstract][Full Text] [Related]
15. Risperidone for chronic schizophrenia.
Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777
[No Abstract] [Full Text] [Related]
16. Amisulpride has no effect on plasma clozapine concentrations.
Bergemann N; Kress KR; Frick A; Kopitz J
J Clin Psychopharmacol; 2005 Oct; 25(5):494-7. PubMed ID: 16160629
[No Abstract] [Full Text] [Related]
17. Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment.
Gee S; Dixon T; Docherty M; Shergill SS
BMC Psychiatry; 2015 Aug; 15():195. PubMed ID: 26265348
[TBL] [Abstract][Full Text] [Related]
18. Rational antipsychotic polypharmacy.
Kennedy NB; Procyshyn RM
Can J Clin Pharmacol; 2000; 7(3):155-9. PubMed ID: 11044761
[TBL] [Abstract][Full Text] [Related]
19. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
20. Case report: Pharmacokinetic interaction between clozapine and mirtazapine.
Lo Presti C; Laguin S; Bambina E; Arlotto E; Aghazarian V; Guise-Honore S
Encephale; 2019 Sep; 45(4):363-364. PubMed ID: 30879778
[No Abstract] [Full Text] [Related]
[Next] [New Search]
